Page last updated: 2024-09-04

rhodioloside and Diabetic Angiopathies

rhodioloside has been researched along with Diabetic Angiopathies in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Hu, R; Liu, LY; Lu, L; Ni, SH; Wang, M; Wang, MQ; Wang, YJ; Wei, LB; Wu, XH; You, HY1

Other Studies

1 other study(ies) available for rhodioloside and Diabetic Angiopathies

ArticleYear
Salidroside ameliorates endothelial inflammation and oxidative stress by regulating the AMPK/NF-κB/NLRP3 signaling pathway in AGEs-induced HUVECs.
    European journal of pharmacology, 2020, Jan-15, Volume: 867

    Topics: AMP-Activated Protein Kinases; Cell Line; Diabetic Angiopathies; Endothelium, Vascular; Glucosides; Glycation End Products, Advanced; Human Umbilical Vein Endothelial Cells; Humans; Inflammasomes; Inflammation; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidative Stress; Phenols; Reactive Oxygen Species; RNA-Seq; Signal Transduction; Transcription Factor RelA

2020